Open AccessThe Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease
Author(s) -
Kalie L. Tommerdahl,
Jessica Kendrick,
Petter Bjornstad
Publication year - 2022
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00020122
Subject(s) - medicine , albuminuria , glycemic , glucagon like peptide 1 , disease , glucagon like peptide 1 receptor , diabetes mellitus , kidney , kidney disease , exenatide , glucagon , type 2 diabetes , endocrinology , insulin , receptor , agonist
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom